BIM
BIIB icon

Bridges Investment Management’s Biogen BIIB Stock Holding History

Bridges Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,700
Closed -$505K – 219
2019
Q4 		$505K Sell
1,700
-4,870
-74% -$1.35M 0.02% 194
2019
Q3 		$1.53M Sell
6,570
-5,599
-46% -$1.3M 0.06% 156
2019
Q2 		$2.85M Sell
12,169
-22,169
-65% -$5.12M 0.11% 106
2019
Q1 		$8.12M Sell
34,338
-913
-3% -$287K 0.33% 70
2018
Q4 		$10.6M Buy
35,251
+9,654
+38% +$3.08M 0.5% 45
2018
Q3 		$9.04M Buy
25,597
+2,562
+11% +$882K 0.45% 56
2018
Q2 		$6.68M Buy
23,035
+974
+4% +$274K 0.3% 72
2018
Q1 		$6.04M Buy
22,061
+7,344
+50% +$2.28M 0.28% 74
2017
Q4 		$4.69M Sell
14,717
-1,525
-9% -$489K 0.38% 60
2017
Q3 		$5.09M Buy
16,242
+3,932
+32% +$1.16M 0.48% 52
2017
Q2 		$3.34M Sell
12,310
-925
-7% -$245K 0.45% 52
2017
Q1 		$3.62M Sell
13,235
-803
-6% -$227K 0.5% 50
2016
Q4 		$3.98M Sell
14,038
-1,400
-9% -$415K 0.56% 44
2016
Q3 		$4.83M Sell
15,438
-275
-2% -$81.4K 0.81% 38
2016
Q2 		$3.8M Buy
15,713
+265
+2% +$69.8K 0.66% 43
2016
Q1 		$4.02M Buy
15,448
+1,225
+9% +$324K 0.73% 40
2015
Q4 		$4.36M Buy
14,223
+2,458
+21% +$706K 0.78% 35
2015
Q3 		$4.75M Hold
11,765
– – 0.82% 33
2015
Q2 		$4.75M Buy
11,765
+2,605
+28% +$1.05M 0.82% 33
2015
Q1 		$3.87M Buy
9,160
+1,680
+22% +$662K 0.68% 36
2014
Q4 		$2.54M Buy
7,480
+2,637
+54% +$853K 0.45% 53
2014
Q3 		$1.6M Hold
4,843
– – 0.3% 67
2014
Q2 		$1.53M Buy
4,843
+335
+7% +$101K 0.29% 68
2014
Q1 		$1.38M Buy
4,508
+658
+17% +$209K 0.29% 65
2013
Q4 		$1.08M Buy
3,850
+25
+0.7% +$6.47K 0.24% 72
2013
Q3 		$921K Buy
3,825
+200
+6% +$44.8K 0.23% 74
2013
Q2 		$780K Buy
+3,625
New +$775K 0.21% 77

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bridges Investment Management's BIIB Position: Q1 2020 in Review

Bridges Investment Management sold out of Biogen (BIIB) in Q1 2020, closing a stake of 1,700 shares — an estimated $505K sold.

Bridges Investment Management first reported a position in BIIB in Q2 2013 and held it in 27 quarters. The position peaked at $10.6M in Q4 2018. 1,100 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Bridges Investment Management reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • Bridges Investment Management sold 1,700 Biogen shares in Q1 2020, an estimated $505K.
  • Bridges Investment Management first reported a position in Biogen in Q2 2013 and held it in 27 quarters.
  • Bridges Investment Management's Biogen position peaked at $10.6M in Q4 2018.
  • 1,100 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Bridges Investment Management's 13F filing for Q1 2020, filed 12 May 2020.